Vitaspring Biomedical (VSBC) Gross Margin (2017 - 2022)
Vitaspring Biomedical (VSBC) reported Gross Margin of 38.12% for fiscal Q1 2023 (quarter ended Apr 30, 2022), down 6.80 percentage points from 44.92% a year earlier and down 3.93 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Gross Margin (2017 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical posted Gross Margin of 36.84%, down 8.36 percentage points from FY2021.
- Gross Margin has a four-year change of -33.04 percentage points (FY2018 to FY2022).
- By fiscal year, Gross Margin came in at 45.21% in FY2021 (+34.01 pp), 11.20% in FY2020 (-68.65 pp), 79.85% in FY2019 (+9.97 pp) and 69.88% in FY2018.
- Five-year quarterly Gross Margin spans a low of -114.99% in fiscal Q4 2020 and a high of 87.95% in fiscal Q4 2019.
- The high point for year-over-year Gross Margin in five years was fiscal Q4 2021 (a gain of 160.19 percentage points); the low point was fiscal Q4 2020 (a drop of 202.93 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2023 came in at 42.05% (Q4 2022), 10.00% (Q3 2022) and 24.54% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2022 | 38.12% |
| Jan 31, 2022 | 42.05% |
| Oct 31, 2021 | 10.00% |
| Jul 31, 2021 | 24.54% |
| Apr 30, 2021 | 44.92% |
| Jan 31, 2021 | 45.21% |
| Jan 31, 2020 | -114.99% |
| Apr 30, 2019 | 87.47% |
| Jan 31, 2019 | 87.95% |
| Oct 31, 2018 | 85.33% |
| Jul 31, 2018 | 79.40% |
| Apr 30, 2018 | 78.16% |
| Jan 31, 2018 | 76.48% |
| Oct 31, 2017 | 85.92% |
| Jul 31, 2017 | 39.08% |
| Apr 30, 2017 | 84.18% |
API Access
Vitaspring Biomedical Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();